Serialization - New service offer from Med-X-Press
The EU security system for prescription medicines was launched on 9 February 2019, accompanied by many discussions: the deadline for implementing the EU Anti-Counterfeiting Directive. The pharmaceutical logistics company Med-X-Press was well prepared and offers pharmaceutical manufacturers company-specific offers for printing the product code and affixing the tamper-evident seal.
In the run-up to this appointment, the stakeholders of the health care system dealt intensively with the implementation of the corresponding tools for counterfeit protection in accordance with EU regulations.
At the pharmaceutical logistics
company Med-X-Press in Goslar, working groups and project groups were formed at
an early stage to develop serialization concepts specifically tailored to the
needs of customers. The result is a comprehensive offer for the printing of
folding boxes of prescription drugs in connection with the application of a
tamper-proof tamper-evident closure. These measures are intended to ensure
complete traceability of the product and to ensure that a drug has not been
opened or manipulated without authorisation prior to delivery to the patient.
Both ensure a high level of protection for patients against counterfeit
medicines in the legal supply chain of medicines. Med-X-Press has conducted
many discussions with pharmaceutical manufacturers to identify the requirements
of manufacturers and implement them in an offer suitable for potential
customers. The logistics provider has
invested in a system at the Goslar site that prints and verifies the prescribed
code for identifying the drug. In the
same process, the package is sealed with the tamper-evident seal.
In order to
meet current customer requirements, Med-X-Press has decided to invest in a
further line. Soon it will also be possible to print unfilled folding boxes
with the serialization code.
These
services, which are of particular interest for smaller batches, are provided by
Med-X-Press within the scope of its manufacturing license according to §13.1 of
the German Medicines Act (AMG). In addition to this outsourcing offer for
pharmaceutical manufacturers, the officially GDP-certified pharmaceutical
logistician realizes the measures specified by the EU directive within the
scope of his wholesale permit according to §52.a AMG. The measures include
checks on incoming goods as well as on returns and their derecognition from the
European security system.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance